Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 October 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 190 pages)

 

Export 10 results:
Author Title Type [ Year(Asc)]
Filters: Author is Castellsague, J.  [Clear All Filters]
2019
C. Rebordosa, Aguado, J., Plana, E., Thomas, S., Frances, A., Lei, A., Garcia-Gil, E., Nuevo, J., Perez-Gutthann, S., and Castellsague, J., “Use of aclidinium did not increase the risk of death in a noninterventional cohort study in the Clinical Practice Research Datalink (CPRD), United Kingdom”, Respir Med, vol. 152, pp. 37-43, 2019.
2018
J. Castellsague, Kuiper, J. G., Pottegard, A., I. Berglind, A., Dedman, D., Gutierrez, L., Calingaert, B., van Herk-Sukel, M. P., Hallas, J., Sundstrom, A., Gallagher, A. M., Kaye, J. A., Pardo, C., Rothman, K. J., and Perez-Gutthann, S., “A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation - JOELLE study)”, Clin Epidemiol, vol. 10, pp. 299-310, 2018.
C. Rebordosa, Plana, E., Aguado, J., Thomas, S., Garcia-Gil, E., Perez-Gutthann, S., and Castellsague, J., “GOLD assessment of COPD severity in the Clinical Practice Research Datalink (CPRD)”, Pharmacoepidemiol Drug Saf, 2018.
J. G. Kuiper, van Herk-Sukel, M. P. P., Castellsague, J., Pottegard, A., Berglind, I. A., Dedman, D., Gutierrez, L., Calingaert, B., Hallas, J., Sundstrom, A., Gallagher, A. M., Kaye, J. A., Pardo, C., Rothman, K. J., and Perez-Gutthann, S., “Use of Topical Tacrolimus and Topical Pimecrolimus in Four European Countries: A Multicentre Database Cohort Study”, Drugs Real World Outcomes, 2018.
2006
C. Huerta, Varas-Lorenzo, C., Castellsague, J., and Rodriguez, L. A. Garcia, “Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population”, Heart, vol. 92, pp. 1610-5, 2006.
2005
C. Huerta, Castellsague, J., Varas-Lorenzo, C., and Rodriguez, L. A. Garcia, “Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population”, Am J Kidney Dis, vol. 45, pp. 531-9, 2005.
2002
J. Castellsague, Garcia-Rodriguez, L. A., Duque, A., and Perez, S., “Risk of serious skin disorders among users of oral antifungals: a population-based study”, BMC Dermatol, vol. 2, p. 14, 2002.
1999
L. A. Garcia Rodriguez, Duque, A., Castellsague, J., Perez-Gutthann, S., and Stricker, B. H., “A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs”, Br J Clin Pharmacol, vol. 48, pp. 847-52, 1999.
1998
J. Castellsague, S. Gutthann, P., and Rodriguez, L. A. Garcia, “Recent epidemiological studies of the association between hormone replacement therapy and venous thromboembolism. A review”, Drug Saf, vol. 18, pp. 117-23, 1998.
1997
P. S. Gutthann, Rodriguez, L. A. Garcia, Castellsague, J., and A. Oliart, D., “Hormone replacement therapy and risk of venous thromboembolism: population based case-control study”, Bmj, vol. 314, pp. 796-800, 1997.
[Page last reviewed 4 October 2019]